IL98988A - Enzymatic preparation of basic fibroblast growth factor - Google Patents

Enzymatic preparation of basic fibroblast growth factor

Info

Publication number
IL98988A
IL98988A IL9898891A IL9898891A IL98988A IL 98988 A IL98988 A IL 98988A IL 9898891 A IL9898891 A IL 9898891A IL 9898891 A IL9898891 A IL 9898891A IL 98988 A IL98988 A IL 98988A
Authority
IL
Israel
Prior art keywords
bfgf
growth factor
thr
fibroblast growth
adduct
Prior art date
Application number
IL9898891A
Other languages
English (en)
Other versions
IL98988A0 (en
Original Assignee
Erba Carlo Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Erba Carlo Spa filed Critical Erba Carlo Spa
Publication of IL98988A0 publication Critical patent/IL98988A0/xx
Publication of IL98988A publication Critical patent/IL98988A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/50—Fibroblast growth factor [FGF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/06—Preparation of peptides or proteins produced by the hydrolysis of a peptide bond, e.g. hydrolysate products
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/50—Fibroblast growth factor [FGF]
    • C07K14/503—Fibroblast growth factor [FGF] basic FGF [bFGF]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Prostheses (AREA)
  • Materials For Medical Uses (AREA)
IL9898891A 1990-08-02 1991-07-29 Enzymatic preparation of basic fibroblast growth factor IL98988A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB909017008A GB9017008D0 (en) 1990-08-02 1990-08-02 Process for the enzymatic preparation of basic fibroblast growth factor

Publications (2)

Publication Number Publication Date
IL98988A0 IL98988A0 (en) 1992-07-15
IL98988A true IL98988A (en) 1997-02-18

Family

ID=10680087

Family Applications (1)

Application Number Title Priority Date Filing Date
IL9898891A IL98988A (en) 1990-08-02 1991-07-29 Enzymatic preparation of basic fibroblast growth factor

Country Status (27)

Country Link
US (1) US5348863A (de)
EP (1) EP0495049B1 (de)
JP (1) JPH05501655A (de)
KR (1) KR100191697B1 (de)
CN (1) CN1033810C (de)
AT (1) ATE152122T1 (de)
AU (1) AU643822B2 (de)
CA (1) CA2066174A1 (de)
CZ (1) CZ286237B6 (de)
DE (1) DE69125810T2 (de)
DK (1) DK0495049T3 (de)
ES (1) ES2103822T3 (de)
FI (1) FI921428A0 (de)
GB (1) GB9017008D0 (de)
GR (1) GR3024111T3 (de)
HU (1) HU212671B (de)
IE (1) IE912729A1 (de)
IL (1) IL98988A (de)
MY (1) MY107334A (de)
NO (1) NO301480B1 (de)
NZ (1) NZ239204A (de)
PH (1) PH31240A (de)
PT (1) PT98544B (de)
RU (1) RU2093519C1 (de)
WO (1) WO1992002539A1 (de)
YU (1) YU48309B (de)
ZA (1) ZA916026B (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0580874A4 (en) * 1992-02-14 1997-02-26 Kaken Pharma Co Ltd Remedy for airway diseases
RU2200573C2 (ru) * 1994-04-21 2003-03-20 Леукотех А/С Связывающий гепарин белок для лечения сепсиса
US5939390A (en) * 1995-03-09 1999-08-17 Novo Nordisk A/S Pharmaceutical composition
US6274712B1 (en) 1997-12-23 2001-08-14 3-Dimensional Pharmaceuticals, Inc. Analogs of human basic fibroblast growth factor mutated at one or more of the positions glutamute 89, aspartate 101 or leucine 137
RU2187118C2 (ru) * 2000-07-13 2002-08-10 Российский научно-исследовательский нейрохирургический институт им. проф. А.Л. Поленова Способ диагностики возможности рецидивов церебральных рацемозных артериовенозных мальформаций
IL141647A0 (en) 2001-02-26 2002-03-10 Yeda Res & Dev Synthetic human peptides and pharmaceutical compositions comprising them for the treatment of systemic lupus erythematosus
CN1747747B (zh) 2003-01-06 2012-09-05 安吉奥开米公司 作为穿过血脑屏障的载体的抑酶肽及类似物
KR20050100616A (ko) 2003-01-14 2005-10-19 테바 파마슈티컬 인더스트리즈 리미티드 전신성 홍반성 낭창의 치료를 위한 펩티드의 비경구 제제
ES2395087T3 (es) 2004-05-05 2013-02-08 Valorisation-Recherche, Société en Commandite Antagonistas del receptor de interleuquina-1, composiciones y métodos de tratamiento
US8618054B2 (en) 2004-05-05 2013-12-31 Valorisation-Rechereche Société en Commandite Interleukin-1 receptor antagonists, compositions, and methods of treatment
WO2007004060A2 (en) 2005-05-05 2007-01-11 Valorisation Hsj, Societe En Commandite Cytokine receptor modulators and uses thereof
US9365634B2 (en) 2007-05-29 2016-06-14 Angiochem Inc. Aprotinin-like polypeptides for delivering agents conjugated thereto to tissues
EP2789628A3 (de) 2007-05-29 2015-03-04 Angiochem Inc. Aprotininähnliche Polypeptide zur Abgabe von an Geweben konjugierten Mitteln
RU2518240C2 (ru) 2008-04-18 2014-06-10 Ангиочем Инк. Композиция, на основе гидрофобных агентов и способ ее получения(варианты)
US8921314B2 (en) 2008-10-15 2014-12-30 Angiochem, Inc. Conjugates of GLP-1 agonists and uses thereof
RU2531591C2 (ru) 2008-10-15 2014-10-20 Ангиокем Инк. Конъюгаты этопозида и доксорубицина для доставки лекарственных средств
MX2011005963A (es) 2008-12-05 2011-09-01 Angiochem Inc Conjugados de neurotensina o analogos de neurotensina y sus usos.
CN102300987A (zh) 2008-12-17 2011-12-28 安吉奥开米公司 膜型-1基质金属蛋白抑制剂及其用途
AU2010239069B2 (en) 2009-04-20 2015-05-14 Angiochem Inc Treatment of ovarian cancer using an anticancer agent conjugated to an Angiopep-2 analog
MX2012000016A (es) 2009-07-02 2012-03-26 Angiochem Inc Conjugados de peptidos multimericos y sus usos.
RU2013103763A (ru) 2010-07-02 2014-08-10 Ангиохем Инк. Короткие и содержащие d-аминокислоты полипептиды для терапевтических конъюгатов и их применения
WO2014185858A1 (en) * 2013-05-16 2014-11-20 Agency For Science, Technology And Research Heparan sulphates
US10471091B2 (en) 2014-11-19 2019-11-12 Agency For Science, Technology And Research Heparan sulphates for use in repair and/or regeneration of skin
US10493012B2 (en) 2014-11-19 2019-12-03 Agency For Science, Technology And Research Cosmetic use of heparan sulphate
US10980892B2 (en) 2015-06-15 2021-04-20 Angiochem Inc. Methods for the treatment of leptomeningeal carcinomatosis
CN105294851B (zh) * 2015-12-07 2019-02-12 中国科学院长春应用化学研究所 与几丁质特异结合的碱性成纤维细胞生长因子及其编码基因、制备方法与应用
CN114965839A (zh) * 2022-05-11 2022-08-30 朗肽生物制药股份有限公司 人碱性成纤维细胞生长因子的肽图分析方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4785079A (en) * 1984-11-09 1988-11-15 The Salk Institute For Biological Studies Isolation of fibroblast growth factor
US4956455A (en) * 1984-03-05 1990-09-11 The Salk Institute For Biological Studies Bovine fibroblast growth factor
US5026839A (en) * 1985-12-17 1991-06-25 Synergen, Inc DNA encoding a basic fibroblast growth factor
DE3811921A1 (de) * 1988-04-09 1989-10-19 Hoechst Ag Verfahren zur herstellung von proteinen, die n-terminal mit prolin beginnen
US5136025A (en) * 1990-04-04 1992-08-04 California Biotechnology Inc. Method to purify basic fibroblast growth factor

Also Published As

Publication number Publication date
DE69125810T2 (de) 1997-08-07
FI921428A7 (fi) 1992-04-01
PH31240A (en) 1998-06-18
IL98988A0 (en) 1992-07-15
HU9201101D0 (en) 1992-08-28
EP0495049A1 (de) 1992-07-22
AU8304491A (en) 1992-03-02
YU131991A (sh) 1994-05-10
HU212671B (en) 1996-09-30
CZ286237B6 (cs) 2000-02-16
EP0495049B1 (de) 1997-04-23
CA2066174A1 (en) 1992-02-03
GB9017008D0 (en) 1990-09-19
KR100191697B1 (ko) 1999-06-15
PT98544B (pt) 1999-01-29
MY107334A (en) 1995-11-30
NZ239204A (en) 1993-11-25
CN1058597A (zh) 1992-02-12
PT98544A (pt) 1992-06-30
NO921236L (no) 1992-03-30
ZA916026B (en) 1992-04-29
JPH05501655A (ja) 1993-04-02
KR920702371A (ko) 1992-09-03
CN1033810C (zh) 1997-01-15
AU643822B2 (en) 1993-11-25
DK0495049T3 (da) 1997-08-25
HUT64564A (en) 1994-01-28
FI921428L (fi) 1992-04-01
NO921236D0 (no) 1992-03-30
GR3024111T3 (en) 1997-10-31
RU2093519C1 (ru) 1997-10-20
WO1992002539A1 (en) 1992-02-20
ES2103822T3 (es) 1997-10-01
IE912729A1 (en) 1992-02-12
ATE152122T1 (de) 1997-05-15
CS236291A3 (en) 1992-02-19
FI921428A0 (fi) 1992-04-01
NO301480B1 (no) 1997-11-03
YU48309B (sh) 1998-05-15
DE69125810D1 (de) 1997-05-28
US5348863A (en) 1994-09-20

Similar Documents

Publication Publication Date Title
IL98988A0 (en) Enzymatic preparation of basic fibroblast growth factor
EP1715057A3 (de) Methoden zur Änderung von Kohlenhydrathälften
GR3023233T3 (en) Inhibitors of dipeptidyl-aminopeptidase type iv
DE69020794D1 (de) Enzymatische Entfernung einer aminoterminalen Proteinsequenz.
ZA947318B (en) Surface loop structural analogues of fibroblast growth factors
EP1277762A3 (de) Niedrigallergene Proteinvarianten
ZA9397B (en) A human kunitz-type protease inhibitor variant
CA2232240A1 (en) Peptide for inhibiting growth of smooth muscle cells
WO1995015161A3 (de) Arzneimittel zur behandlung der herzinsuffizienz
CA2035917A1 (en) Stabilized sulfonate, sulfate, phosphonate and phosphate derivatives of hirudin
ES2147233T3 (es) Procedimiento de realizacion de motivos sobre objetos, especialmente articulos de ceramica.
EP0992513A3 (de) Isolierte Metallopeptide, Zusammensetzungen und Methoden zur Synthese
IT1237490B (it) Procedimento per la sintesi della 1 n (s delta ammino alfa idrossibutirril)kamanycin a basato sul trattamento della 1 n (s delta benzilossicarbonilammino alfa idrossibutirril) 3,6' di n benzilossicarbonilkanamycin a con acido formico
SE9000793D0 (sv) Sdk-peptider,foerfarande foer framstaellning daerav och terapeutiska kompositioner innehaallande dem
DE59805677D1 (de) Froststabilisierung von wässrigen überzugsmitteln durch frostschutzproteine
IT9045744A0 (it) Procedimento per la fabbricazione di rivestimenti decorativi per i mobili d'arredamento
CA2234504A1 (en) Implantable tubular prosthesis
Trickett BS 5750: Implications?
MY114151A (en) Analogs of thymosin
Kadima Strategies for the Immobilization of Chloroperoxidase
WO1991012344A3 (de) Salze sulfonierter phosphorsäureester als lederfettungsmittel
HUT58832A (en) Galvanising bath for process for producing decorative chromine coating

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
RH Patent void